Variable | HAART initiated (n=126) | Non-HAART (n=126) | |
---|---|---|---|
N (%) | N (%) | ||
Gender | Female | 86(68.3) | 96(76.2) |
Male | 40(31.7) | 30(23.8) | |
Age group (years) | Mean ± SD | 37.1(9.8) | 33.4(10.2) |
18-29 | 25(19.8) | 51(40.5)** | |
30-39 | 61(48.4) | 49(38.9) | |
40-49 | 25(19.8) | 16(12.7) | |
≥50 | 15(11.9) | 10(7.9) | |
BMI | Mean ± SD | 21.9(3.2) | 20.8(2.8) |
<18.5 | 9(7.1) | 24(19)* | |
18.5-24.9 | 97(77) | 91(72.2) | |
25-29.9 | 17(13.5) | 10(7.9) | |
≥30 | 3(2.4) | 1(0.8) | |
CD4+ cells (cells/mm3) | Mean ± SD | 314.5 ± 152.5 | 413.6 ± 246.2 |
<200 | 34(27) | 25(19.8)** | |
200-400 | 58(46) | 42(33.3) | |
>400 | 34(27) | 59(46.8) | |
Duration of HIV infection (month) | Mean ± SD | 29.5(17) | 11.8(12.3) |
<6 | 0(0) | 57(45.2)*** | |
6-12 | 22(17.5) | 21(16.7) | |
13-24 | 22(17.5) | 27(21.4) | |
25-41 | 59(46.8) | 19(15.1) | |
≥42 | 23(18.3) | 2(1.6) | |
TB Co-infection | Present | 21(16.7) | 18(14.3) |
Not present | 105(83.3) | 108(85.7) |